mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concern
Summary: SARS-CoV-2 variants of concern (VOCs) have shown resistance to vaccines targeting the original virus strain. An mRNA vaccine encoding the spike protein of Omicron BA1 (BA1-S-mRNA) was designed, and its neutralizing activity, with or without the original receptor-binding domain (RBD)-mRNA, w...
Main Authors: | Gang Wang, Juan Shi, Abhishek K. Verma, Xiaoqing Guan, Stanley Perlman, Lanying Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222019630 |
Similar Items
-
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
by: Xiaoqing Guan, et al.
Published: (2023-10-01) -
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern
by: Melissa García-Vega, et al.
Published: (2023-04-01) -
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
by: Alexandra Tauzin, et al.
Published: (2023-01-01) -
Additional mutations based on Omicron BA.2.75 mediate its further evasion from broadly neutralizing antibodies
by: Huimin Guo, et al.
Published: (2023-04-01) -
Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8+ T cells against SARS-CoV-2 variants
by: Kate A. Parham, et al.
Published: (2023-04-01)